Bio-Techne (TECH) Asset Utilization Ratio (2010 - 2026)
Bio-Techne (TECH) recorded quarterly Asset Utilization Ratio of 0.48 in Q1 2026, down 0.87% quarter-over-quarter from 0.48 in Q4 2025, and up 4.93% on a YoY basis from 0.45 in Q1 2025.
Bio-Techne (TECH) Asset Utilization Ratio (2010 - 2026) Analysis & Trends
Bio-Techne's Asset Utilization Ratio history runs 17 years deep, the most recent figure standing at 0.48 for Q1 2026.
- In Q1 2026, Asset Utilization Ratio rose 4.93% year-over-year to 0.48; the TTM figure through Mar 2026 stood at 0.48 (up 4.93% YoY), while the FY2025 annual figure was 0.46, up 6.84% from the prior year.
- Asset Utilization Ratio was 0.48 for Q1 2026 at Bio-Techne, down from 0.48 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 0.48 in Q4 2025 to a low of 0.33 in Q2 2023.
- Historically, Asset Utilization Ratio has averaged 0.43 across 5 years, with a median of 0.43 in 2024.
- The sharpest annual moves came in 2023 and 2024: Asset Utilization Ratio slumped 31.05% in 2023, then increased 28.78% in 2024.
- A 5-year view of Asset Utilization Ratio shows it stood at 0.36 in 2022, then gained by 15.45% to 0.42 in 2023, then rose by 5.99% to 0.44 in 2024, then climbed by 8.83% to 0.48 in 2025, then declined by 0.87% to 0.48 in 2026.
- The last three Asset Utilization Ratio figures came in at 0.48 (Q1 2026), 0.48 (Q4 2025), and 0.48 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 0.55 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.60 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 1,422.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 0.47 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Bio-Techne | 9.04 Bn | 8.83 Bn | 208.29 Mn | 0.48 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.48 |
| Dec 31, 2025 | 0.48 |
| Sep 30, 2025 | 0.48 |
| Jun 30, 2025 | 0.47 |
| Mar 31, 2025 | 0.45 |
| Dec 31, 2024 | 0.44 |
| Sep 30, 2024 | 0.43 |
| Jun 30, 2024 | 0.43 |
| Mar 31, 2024 | 0.42 |
| Dec 31, 2023 | 0.42 |
| Sep 30, 2023 | 0.42 |
| Jun 30, 2023 | 0.33 |
| Mar 31, 2023 | 0.34 |
| Dec 31, 2022 | 0.36 |
| Sep 30, 2022 | 0.37 |
| Jun 30, 2022 | 0.48 |
| Mar 31, 2022 | 0.47 |
| Dec 31, 2021 | 0.45 |
| Sep 30, 2021 | 0.43 |
| Jun 30, 2021 | 0.43 |